Cumberland Pharmaceuticals (CPIX) Cash from Discontinued Operations (2019 - 2021)

Cumberland Pharmaceuticals has disclosed Cash from Discontinued Operations across 3 years of filings, most recently posting 503318.0 for Q4 2021.

• Cash from Discontinued Operations for Q4 2021 came in at 503318.0, down 62.78% year-over-year; the trailing twelve-month figure through Sep 2022 was 503318.0 (down 82.3% YoY), and the FY2021 annual result was 1994322.0, down 43.31% from the prior year.
• Cash from Discontinued Operations came in at 503318.0 for Q4 2021 at Cumberland Pharmaceuticals, up from 496787.0 in the prior quarter.
• In the past five years, Cash from Discontinued Operations ranged from a high of 3027800.0 in Q4 2019 to a low of 38567.0 in Q2 2020.
• The 3-year median for Cash from Discontinued Operations is 648983.5 (2020), against an average of 918680.0.
• Across the five-year window, Cash from Discontinued Operations tumbled 97.11% in 2020 and surged 1193.35% in 2021, its largest moves.
• Cumberland Pharmaceuticals' Cash from Discontinued Operations stood at 3027800.0 in 2019, then sank by 55.34% to 1352156.0 in 2020, then sank by 62.78% to 503318.0 in 2021.
• The last three Cash from Discontinued Operations figures came in at 503318.0 (Q4 2021), 496787.0 (Q3 2021), and 498807.0 (Q2 2021), per Business Quant data.